This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riemer, C.
Right arrow Articles by Baier, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riemer, C.
Right arrow Articles by Baier, M.

 Previous Article  |  Next Article 

Journal of Virology, November 2000, p. 10245-10248, Vol. 74, No. 21
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Identification of Upregulated Genes in Scrapie-Infected Brain Tissue

Constanze Riemer, Ingo Queck, Dietrich Simon, Reinhard Kurth, and Michael Baier*

Robert-Koch-Institut, 13353 Berlin, Germany

Received 4 May 2000/Accepted 2 August 2000


    ABSTRACT
Top
Abstract
Text
References

The pathogenesis of scrapie, and of neurodegenerative diseases in general, is still insufficiently understood and is therefore being intensely researched. There is abundant evidence that the activation of glial cells precedes neurodegeneration and may thus play an important role in disease development and progression. The identification of genes with altered expression patterns in the diseased brain may provide insight on the molecular level into the process which ultimately leads to neuronal loss. Differentially expressed genes in scrapie-infected brain tissue were enriched by the suppression subtractive hybridization technique, molecularly cloned, and further characterized. Northern blotting and nucleotide sequencing confirmed the identities of 19 upregulated genes, 11 of which were unknown to be affected by scrapie. A considerable number of these 19 genes, namely those encoding interferon-inducible protein 10 (IP-10), 2',5'-oligo(A) synthetase, Mx protein, IIGP protein, major histocompatibility complex classes I and II, complement, and beta 2-microglobulin, were inducible by interferons (IFNs), suggesting that an IFN response is a possible mechanism of gene activation in scrapie. Among the newly found genes, that coding for 2',5'-oligo(A) synthetase is of special interest because it could contribute to the apoptotic loss of neuronal cells via RNase L activation. In addition, upregulation of the chemokine IP-10 and B-lymphocyte chemoattractant mRNAs was seen at relatively early stages of the disease and was sustained throughout disease development.


    TEXT
Top
Abstract
Text
References

Scrapie, a naturally occurring disease of sheep and goats, and the corresponding pathologies in humans (Creutzfeldt-Jakob disease, Gerstmann-Sträussler-Scheinker syndrome, fatal familial insomnia, and Kuru), cattle (bovine spongiform encephalopathy), and other animals are transmissible progressive neurodegenerative disorders (1, 4, 7, 11, 28). The neuropathology of these transmissible spongiform encephalopathies (TSEs) is usually linked to the appearance of an abnormal insoluble and protease-resistant form of a normal host-encoded protein, the prion protein (PrP). Structurally, the disease-associated abnormal form of PrP, termed PrPres or PrPSc, is characterized by a high beta-sheet content in contrast to the predominantly alpha-helical fold of normal PrP (10, 23, 33).

TSEs in general are characterized by a reactive gliosis and the subsequent degeneration of neuronal tissue. The activation of glial cells, which precedes neuronal death, is likely to be caused by the deposition of large amounts of PrPSc in the brain (21, 36, 37). Experimental evidence suggests that PrPSc participates in initiation of the gliosis and subsequent neuronal loss, since a PrP-derived peptide (PrP106-126) activates microglial cells in vitro (6, 20). Furthermore, cell culture supernatants from these stimulated cells induce the proliferation of astrocytes and are toxic to neuronal cells (5). Thus, cytokines released by PrPSc-activated microglial cells may contribute to scrapie pathogenesis by enhancement and generalization of the gliosis and via cytotoxicity to neurons. However, the mechanisms of PrPSc-triggered microglial activation and many of the factors involved are still unknown. A more complete understanding of the disease may help researchers to define possible therapeutic targets and to develop new means of diagnosis.

To identify upregulated genes in the scrapie-infected hamster brain which may be associated with or even cause the neurodegenerative changes, a strategy using the suppression subtractive hybridization (SSH) technique in combination with a differential screening approach was chosen (13). Briefly, hamsters were inoculated intraperitoneally (i.p.) with scrapie strain 263K (16). Control animals were inoculated with the same volume of normal-brain homogenate. Following total-brain RNA isolation at the terminal stage of the infection, synthesis and subtraction of the cDNA pools were carried out with an SSH-based PCR-select cDNA subtraction kit (Clontech, Palo Alto, Calif.) according to the manufacturer's suggestions. Remaining cDNAs were randomly subcloned into a T/A vector (Invitrogen, Carlsbad, Calif.).

In total, 1,200 clones generated by the SSH procedure were analyzed by dot blotting with forward and reverse subtracted cDNA probes from infected and uninfected hamster brain tissue, respectively. One hundred clones displayed signal intensity differences and were further characterized by nucleotide sequencing. Sequence database searches identified eight genes previously described as being upregulated in the scrapie-infected brain (GFAP, transferrin, apolipoprotein J, metallothionein, beta 2-microglobulin, major histocompatibility complex [MHC] class I, MHC class II, and MHC class II-associated invariant chain). Northern blot analysis of the remaining clones confirmed that 11 genes which had previously been unknown to be affected by the scrapie infection were differentially expressed: IP-10, BLC, Mx protein, 2',5'-oligo(A) synthetase, IIGP protein, glycoprotein 39 precursor (gp39), vimentin, aquaporin 4 (AQP-4), lysosome-associated multitransmembrane protein (LAPTm5), the LIM homeodomain protein 7 (Lhx7), and the C1q C chain of complement (Table 1; Fig. 1).

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Upregulated genes in the scrapie-infected hamster brain



View larger version (80K):
[in this window]
[in a new window]
  		FIG. 1.   Northern blot analysis of upregulated genes in the scrapie-infected hamster brain. RNA (10 µg/lane) was fractionated by agarose gel electrophoresis, transferred to nylon membranes, and hybridized with clones IP-10 (a), BLC (b), Mx protein (c), 2',5'-oligo(A) synthetase (d), IIGP protein (e), gp-39 precursor (f), vimentin (g) AQP-4 (h), LAPTm5 (i), Lhx 7 (j), C1q C chain of complement (k), GFAP (l), and beta -actin control (m). Control, RNA from two mock-infected hamsters; scrapie, RNA from two scrapie-infected hamsters at the terminal stage of the disease.

The levels of mRNA induction in scrapie-infected brain among the 19 different genes ranged from 1.5- to 6-fold compared to those of uninfected controls as determined by Northern blotting and subsequent densitometric quantification. Only the IP-10 mRNA was virtually undetectable in uninfected brain tissue and was highly expressed in the terminal stage of the infection (Fig. 1). In addition, expression of the chemokines IP-10 and BLC in the brains of BALB/c mice i.p. infected with scrapie strain 139A was analyzed over time. By using a semiquantitative reverse transcription (RT)-PCR method, both chemokines were found to be induced at day 114 postinfection, which was about 90 days before the terminal stage of the disease (Fig. 2). Even with the highly sensitive RT-PCR, no IP-10 mRNA was seen in the normal mouse brain tissue.


View larger version (30K):
[in this window]
[in a new window]
  		FIG. 2.   Time point of IP-10 and BLC upregulation. RNA from scrapie-infected BALB/c mice was isolated on the days postinfection indicated at the top of the figure. RNA from mock-infected animals, sacrificed at 202 days postinfection, served as controls (C). Further RT-PCR controls were carried out without template (neg1) and with RNA but no prior cDNA synthesis to check for DNA contamination of the RNA preparation (neg2). RT-PCRs were performed with gene-specific primers for IP-10 (3' primer, GCT GCA ACT GCA TCC ATA TCG A; 5' primer, TTG GCT AAA CGC TTT CAT TAA ATT C) (a), for BLC (3' primer: TCA GCA CAG CAA CGC TGC TTC T; 5' primer, CTG GAG CTT GGG GAG TTG AAG A) (b), and for glycerol-3-phosphate dehydrogenase (G3PDH; to control the amounts and quality of the RNAs used) (3' primer, TCC ACC ACC CTG TTG CTG TA; 5' primer, ACC ACA GTC CAT GCC ATC AC) (c) under standard conditions. Ten microliters of each reaction mixture was loaded on an agarose gel and, after electrophoresis, visualized by ethidium bromide staining.

Previous research efforts employed methods like immunohistochemistry, in situ hybridization, subtractive hybridization, and differential-display RT-PCR to analyze gene or protein expression alterations in the scrapie-infected brain (12, 15, 17, 18). Most importantly, proinflammatory cytokines (e.g., tumor necrosis factor alpha, interleukin-1 [IL-1], and IL-6), glial cell activation markers (e.g., GFAP, cathepsin S, and complement C1q), and indicators of cellular stress (e.g., HSP70 and metallothionein II) were found to be upregulated in the scrapie-infected brain (8, 12, 14, 25, 35, 36). The more recently developed SSH technique, a powerful tool for the analysis of differential gene expression, was used in this study to increase our current understanding of the pathological changes in the scrapie-infected brain on the molecular level.

In total, we found 19 upregulated genes (Table 1), 8 of which were previously described by other groups as being differentially expressed. Among the 11 genes newly found to be affected by scrapie infection, IP-10, BLC, vimentin, gp39, LAPTm5, AQP-4, and the C1q C chain of complement are most likely expressed by activated glial cells. Increased vimentin and AQP-4 levels are indicative of an ongoing astrocytosis (27, 32). Among the microgliosis markers, gp39 is seen in late stages of macrophage differentiation and is thus probably expressed by activated and differentiating microglial cells. Upregulation of the C chain of complement C1q in stimulated microglial cells is in agreement with a similar observation for the C1q B chain (12). High LAPTm5 expression levels are associated with an increased lysosomal activity of microglial cells in the vicinity of spongiform histological changes (37). This observation further substantiates the possible involvement of an aberrant activation of the microglial lysosomal system in neurodegeneration (26).

2',5'-Oligo(A) synthetase is most likely expressed by glial as well as neuronal cells (2). 2',5'-Oligo(A) synthetase causes activation of RNase L, which has been demonstrated to participate in apoptotic cell death via its nonspecific rRNA-degrading activity (9, 39). Hence, activation of RNase L may directly contribute to neuronal loss in scrapie. In contrast to the upregulation of IP-10 and BLC at day 114 postinfection, increasing 2',5'-oligo(A) synthetase mRNA levels were first seen at day 141 by RT-PCR (data not shown).

It is less clear which cell types express increased levels of the GTPase IIGP, the putative transcription factor Lhx7 mRNA, and the Mx protein. Mx protein and 2',5'-oligo(A) synthetase are part of the antiviral response induced by interferons (IFNs). Moreover, given that the expression of IIGP, MHC classes I and II, complement, beta 2-microglobulin, and IP-10 is also IFN inducible, gene activation in scrapie bears all of the hallmarks of a typical IFN response. Interestingly, gamma IFN (IFN-gamma ) was previously shown to activate microglia after stimulation with beta -amyloid (31). Furthermore, low doses of IFN-gamma , but not IL-1beta , IL-2, IL-4, IL-6, or IL-12, synergistically enhance CD40 expression on microglial cells upon stimulation with beta -amyloid. Thus, IFN-gamma may contribute to the CD40-CD40L interaction-dependent activation of microglia in Alzheimer's disease as well as in scrapie (34). We are presently investigating the role of IFN-gamma in the pathogenesis of scrapie by looking at scrapie infections of IFN-gamma receptor knockout mice in comparison to wild-type controls.

The chemokines IP-10 and BLC, so far only known as chemoattractants for T and B cells (19, 22, 29), respectively, are likely to be produced by activated glial cells (30). However, since infiltrating lymphoid cells are rarely observed in scrapie, IP-10 and BLC may bind to other target cells in the brain rather than to cells in lymphoid organs. Evidence for chemokine receptor expression on neurons surrounding amyloid plaques in Alzheimer's disease suggests that neuronal cells, in addition to glial cells, may well be potential targets for IP-10 and BLC (24, 38). Studies of chemokine expression and function in the normal and the diseased brain are still in their early stages, and we currently do not know the effects of IP-10 and BLC on receptor-expressing neurons. The induction of both chemokines is seen at early stages of the scrapie infection and is sustained at high levels until the end, which indicates an involvement in disease progression. Increased levels of IP-10 and BLC mRNAs were seen in two species infected with different scrapie strains. Thus, this observation is likely to be of general relevance in TSEs and less variable than the levels of transforming growth factor beta 1 and cathepsin S seen in different TSE model systems (3). Finally, given that chemokine mRNA levels are early markers for infection, determination of chemokine levels in the brain and in cerebrospinal fluid is potentially useful for the differential diagnosis of TSEs.


    ACKNOWLEDGMENTS

This work was funded in part by the Hertie Stiftung.

We thank E. Baldauf and U. Erikli for help in manuscript preparation and M. Beekes and H. Diringer for helpful discussions.


    FOOTNOTES

* Corresponding author. Mailing address: Robert-Koch-Institut, Nordufer 20, 13353 Berlin, Germany. Phone: 49-30-45472230. Fax: 49-30-45472609. E-mail: baierm{at}rki.de.


    REFERENCES
Top
Abstract
Text
References

1. Aguzzi, A., and C. Weissmann. 1997. Prion research: the next frontiers. Nature 389:795-798[CrossRef][Medline].
2. Asada-Kubota, M., T. Ueda, T. Nakashima, M. Kobayashi, M. Shimada, K. Takeda, K. Hamada, S. Maekawa, and Y. Sokawa. 1997. Localization of 2',5'-oligoadenylate synthetase and the enhancement of its activity with recombinant interferon-alpha A/D in the mouse brain. Anat. Embryol. 195:251-257[CrossRef][Medline].
3. Baker, C. A., Z. Y. Lu, I. Zaitsev, and L. Manuelidis. 1999. Microglial activation varies in different models of Creutzfeldt-Jakob disease. J. Virol. 73:5089-5097[Abstract/Free Full Text].
4. Bons, N., N. Mestre-Frances, P. Belli, F. Cathala, D. C. Gajdusek, and P. Brown. 1999. Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc. Natl. Acad. Sci. USA 96:4046-4051[Abstract/Free Full Text].
5. Brown, D. R., and H. A. Kretzschmar. 1997. Microglia and prion disease: a review. Histol. Histopathol. 12:883-892[Medline].
6. Brown, D. R., B. Schmidt, and H. A. Kretzschmar. 1996. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380:345-347[CrossRef][Medline].
7. Brown, P., and D. C. Gajdusek. 1991. The human spongiform encephalopathies: kuru, Creutzfeldt-Jakob disease, and the Gerstmann-Straussler-Scheinker syndrome. Curr. Top. Microbiol. Immunol. 172:1-20[Medline].
8. Campbell, I. L., M. Eddleston, P. Kemper, M. B. Oldstone, and M. V. Hobbs. 1994. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J. Virol. 68:2383-2387[Abstract/Free Full Text].
9. Castelli, J. C., B. A. Hassel, K. A. Wood, X. L. Li, K. Amemiya, M. C. Dalakas, P. F. Torrence, and R. J. Youle. 1997. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J. Exp. Med. 186:967-972[Abstract/Free Full Text].
10. Caughey, B., G. J. Raymond, and R. A. Bessen. 1998. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J. Biol. Chem. 273:32230-32235[Abstract/Free Full Text].
11. Chesebro, B. 1997. Human TSE disease---viral or protein only? Nat. Med. 3:491-492[CrossRef][Medline].
12. Dandoy-Dron, F., F. Guillo, L. Benboudjema, J. P. Deslys, C. Lasmezas, D. Dormont, M. G. Tovey, and M. Dron. 1998. Gene expression in scrapie. Cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts. J. Biol. Chem. 273:7691-7697[Abstract/Free Full Text].
13. Diatchenko, L., Y. F. Lau, A. P. Campbell, A. Chenchik, F. Moqadam, B. Huang, S. Lukyanov, K. Lukyanov, N. Gurskaya, E. D. Sverdlov, and P. D. Siebert. 1996. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl. Acad. Sci. USA 93:6025-6030[Abstract/Free Full Text].
14. Diedrich, J., S. Wietgrefe, M. Zupancic, K. Staskus, E. Retzel, A. T. Haase, and R. Race. 1987. The molecular pathogenesis of astrogliosis in scrapie and Alzheimer's disease. Microb. Pathog. 2:435-442[CrossRef][Medline].
15. Diedrich, J. F., H. Minnigan, R. I. Carp, J. N. Whitaker, R. Race, W. Frey II, and A. T. Haase. 1991. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol. 65:4759-4768[Abstract/Free Full Text].
16. Diringer, H., J. Roehmel, and M. Beekes. 1998. Effect of repeated oral infection of hamsters with scrapie. J. Gen. Virol. 79:609-612[Abstract].
17. Doh-ura, K., S. Perryman, R. Race, and B. Chesebro. 1995. Identification of differentially expressed genes in scrapie-infected mouse neuroblastoma cells. Microb. Pathog. 18:1-9[Medline].
18. Duguid, J. R., R. G. Rohwer, and B. Seed. 1988. Isolation of cDNAs of scrapie-modulated RNAs by subtractive hybridization of a cDNA library. Proc. Natl. Acad. Sci. USA 85:5738-5742[Abstract/Free Full Text].
19. Farber, J. M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61:246-257[Abstract].
20. Forloni, G., N. Angeretti, R. Chiesa, E. Monzani, M. Salmona, O. Bugiani, and F. Tagliavini. 1993. Neurotoxicity of a prion protein fragment. Nature 362:543-546[CrossRef][Medline].
21. Giese, A., D. R. Brown, M. H. Groschup, C. Feldmann, I. Haist, and H. A. Kretzschmar. 1998. Role of microglia in neuronal cell death in prion disease. Brain Pathol. 8:449-457[Medline].
22. Gunn, M. D., V. N. Ngo, K. M. Ansel, E. H. Ekland, J. G. Cyster, and L. T. Williams. 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391:799-803[CrossRef][Medline].
23. Hope, J., and J. Manson. 1991. The scrapie fibril protein and its cellular isoform. Curr. Top. Microbiol. Immunol. 172:57-74[Medline].
24. Horuk, R., A. W. Martin, Z. Wang, L. Schweitzer, A. Gerassimides, H. Guo, Z. Lu, J. Hesselgesser, H. D. Perez, J. Kim, J. Parker, T. J. Hadley, and S. C. Peiper. 1997. Expression of chemokine receptors by subsets of neurons in the central nervous system. J. Immunol. 158:2882-2890[Abstract].
25. Kenward, N., J. Hope, M. Landon, and R. J. Mayer. 1994. Expression of polyubiquitin and heat-shock protein 70 genes increases in the later stages of disease progression in scrapie-infected mouse brain. J. Neurochem. 62:1870-1877[Medline].
26. Kopacek, J., S. Sakaguchi, K. Shigematsu, N. Nishida, R. Atarashi, R. Nakaoke, R. Moriuchi, M. Niwa, and S. Katamine. 2000. Upregulation of the genes encoding lysosomal hydrolases, a perforin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease. J. Virol. 74:411-417[Abstract/Free Full Text].
27. Lafarga, M., M. T. Berciano, I. Saurez, M. A. Andres, and J. Berciano. 1993. Reactive astroglia-neuron relationships in the human cerebellar cortex: a quantitative, morphological and immunocytochemical study in Creutzfeldt-Jakob disease. Int. J. Dev. Neurosci. 11:199-213[CrossRef][Medline].
28. Lasmezas, C. I., J. P. Deslys, R. Demalmay, K. T. Adjou, F. Lamoury, D. Dormont, O. Robain, J. Ironside, and J. J. Hauw. 1996. BSE transmission to macaques. Nature 381:743-744[CrossRef][Medline].
29. Legler, D. F., M. Loetscher, R. S. Roos, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1998. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 187:655-660[Abstract/Free Full Text].
30. Majumder, S., L. Z. Zhou, and R. M. Ransohoff. 1996. Transcriptional regulation of chemokine gene expression in astrocytes. J. Neurosci. Res. 45:758-769[CrossRef][Medline].
31. Meda, L., M. A. Cassatella, G. I. Szendrei, L. Otvos, Jr., P. Baron, M. Villalba, D. Ferrari, and F. Rossi. 1995. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374:647-650[CrossRef][Medline].
32. Nielsen, S., E. A. Nagelhus, M. Amiry-Moghaddam, C. Bourque, P. Agre, and O. P. Ottersen. 1997. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J. Neurosci. 17:171-180[Abstract/Free Full Text].
33. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. USA 95:13363-13383[Abstract/Free Full Text].
34. Tan, J., T. Town, D. Paris, T. Mori, Z. Suo, F. Crawford, M. P. Mattson, R. A. Flavell, and M. Mullan. 1999. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 286:2352-2355[Abstract/Free Full Text].
35. Wietgrefe, S., M. Zupancic, A. Haase, B. Chesebro, R. Race, W. Frey II, T. Rustan, and R. L. Friedman. 1985. Cloning of a gene whose expression is increased in scrapie and in senile plaques in human brain. Science 230:1177-1179[Abstract/Free Full Text].
36. Williams, A., A. M. Van Dam, D. Ritchie, P. Eikelenboom, and H. Fraser. 1997. Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations. Brain Res. 754:171-180[CrossRef][Medline].
37. Williams, A. E., L. J. Lawson, V. H. Perry, and H. Fraser. 1994. Characterization of the microglial response in murine scrapie. Neuropathol. Appl. Neurobiol. 20:47-55[Medline].
38. Xia, M. Q., and B. T. Hyman. 1999. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J. Neurovirol. 5:32-41[Medline].
39. Zhou, A., J. Paranjape, T. L. Brown, H. Nie, S. Naik, B. Dong, A. Chang, B. Trapp, R. Fairchild, C. Colmenares, and R. H. Silverman. 1997. Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L. EMBO J. 16:6355-6363[CrossRef][Medline].

Journal of Virology, November 2000, p. 10245-10248, Vol. 74, No. 21
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Bach, C., Gilch, S., Rost, R., Greenwood, A. D., Horsch, M., Hajj, G. N. M., Brodesser, S., Facius, A., Schadler, S., Sandhoff, K., Beckers, J., Leib-Mosch, C., Schatzl, H. M., Vorberg, I. (2009). Prion-induced Activation of Cholesterogenic Gene Expression by Srebp2 in Neuronal Cells. J. Biol. Chem. 284: 31260-31269 [Abstract] [Full Text]  
  • Tribouillard-Tanvier, D., Striebel, J. F., Peterson, K. E., Chesebro, B. (2009). Analysis of Protein Levels of 24 Cytokines in Scrapie Agent-Infected Brain and Glial Cell Cultures from Mice Differing in Prion Protein Expression Levels. J. Virol. 83: 11244-11253 [Abstract] [Full Text]  
  • Guillerme-Bosselut, F., Forestier, L., Jayat-Vignoles, C., Vilotte, J.-L., Popa, I., Portoukalian, J., Le Dur, A., Laude, H., Julien, R., Gallet, P.-F. (2009). Glycosylation-related gene expression profiling in the brain and spleen of scrapie-affected mouse. Glycobiology 19: 879-889 [Abstract] [Full Text]  
  • Flores-Langarica, A., Sebti, Y., Mitchell, D. A., Sim, R. B., MacPherson, G. G. (2009). Scrapie Pathogenesis: The Role of Complement C1q in Scrapie Agent Uptake by Conventional Dendritic Cells. J. Immunol. 182: 1305-1313 [Abstract] [Full Text]  
  • Riemer, C., Schultz, J., Burwinkel, M., Schwarz, A., Mok, S. W. F., Gultner, S., Bamme, T., Norley, S., van Landeghem, F., Lu, B., Gerard, C., Baier, M. (2008). Accelerated Prion Replication in, but Prolonged Survival Times of, Prion-Infected CXCR3-/- Mice. J. Virol. 82: 12464-12471 [Abstract] [Full Text]  
  • Sawiris, G. P., Becker, K. G., Elliott, E. J., Moulden, R., Rohwer, R. G. (2007). Molecular analysis of bovine spongiform encephalopathy infection by cDNA arrays. J. Gen. Virol. 88: 1356-1362 [Abstract] [Full Text]  
  • Rempel, J. D., Quina, L. A., Blakely-Gonzales, P. K., Buchmeier, M. J., Gruol, D. L. (2005). Viral Induction of Central Nervous System Innate Immune Responses. J. Virol. 79: 4369-4381 [Abstract] [Full Text]  
  • Booth, S., Bowman, C., Baumgartner, R., Sorensen, G., Robertson, C., Coulthart, M., Phillipson, C., Somorjai, R. L. (2004). Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection. J. Gen. Virol. 85: 3459-3471 [Abstract] [Full Text]  
  • Xiang, W., Windl, O., Wunsch, G., Dugas, M., Kohlmann, A., Dierkes, N., Westner, I. M., Kretzschmar, H. A. (2004). Identification of Differentially Expressed Genes in Scrapie-Infected Mouse Brains by Using Global Gene Expression Technology. J. Virol. 78: 11051-11060 [Abstract] [Full Text]  
  • Rappert, A., Bechmann, I., Pivneva, T., Mahlo, J., Biber, K., Nolte, C., Kovac, A. D., Gerard, C., Boddeke, H. W. G. M., Nitsch, R., Kettenmann, H. (2004). CXCR3-Dependent Microglial Recruitment Is Essential for Dendrite Loss after Brain Lesion. J. Neurosci. 24: 8500-8509 [Abstract] [Full Text]  
  • Schultz, J., Schwarz, A., Neidhold, S., Burwinkel, M., Riemer, C., Simon, D., Kopf, M., Otto, M., Baier, M. (2004). Role of Interleukin-1 in Prion Disease-Associated Astrocyte Activation. Am. J. Pathol. 165: 671-678 [Abstract] [Full Text]  
  • Uthaiah, R. C., Praefcke, G. J. K., Howard, J. C., Herrmann, C. (2003). IIGP1, an Interferon-{gamma}-inducible 47-kDa GTPase of the Mouse, Showing Cooperative Enzymatic Activity and GTP-dependent Multimerization. J. Biol. Chem. 278: 29336-29343 [Abstract] [Full Text]  
  • Baier, M., Norley, S., Schultz, J., Burwinkel, M., Schwarz, A., Riemer, C. (2003). Prion diseases: infectious and lethal doses following oral challenge. J. Gen. Virol. 84: 1927-1929 [Abstract] [Full Text]  
  • Baker, C. A., Manuelidis, L. (2003). Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 100: 675-679 [Abstract] [Full Text]  
  • Baker, C. A., Martin, D., Manuelidis, L. (2002). Microglia from Creutzfeldt-Jakob Disease-Infected Brains Are Infectious and Show Specific mRNA Activation Profiles. J. Virol. 76: 10905-10913 [Abstract] [Full Text]  
  • Boztug, K., Carson, M. J., Pham-Mitchell, N., Asensio, V. C., DeMartino, J., Campbell, I. L. (2002). Leukocyte Infiltration, But Not Neurodegeneration, in the CNS of Transgenic Mice with Astrocyte Production of the CXC Chemokine Ligand 10. J. Immunol. 169: 1505-1515 [Abstract] [Full Text]  
  • Kneipp, J., Beekes, M., Lasch, P., Naumann, D. (2002). Molecular Changes of Preclinical Scrapie Can Be Detected by Infrared Spectroscopy. J. Neurosci. 22: 2989-2997 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riemer, C.
Right arrow Articles by Baier, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riemer, C.
Right arrow Articles by Baier, M.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»